YOUR HEALTHCARE SOLUTIONS PARTNERS
NEED MORE INFORMATION
Biotronix Healthcare Customer Service Associates are available 8:30am to 5:pm EST Monday thru Friday
North America Customer Service
Tel: (954) 320-6088
International Customer Service
Tel: (289) 813-0159
Sales and Orders
Tel: (954) 266-8944
Call to speak with a knowledgeable Biotronix Healthcare specialist today.
FILTERS AND HME’S
CENTRAL VENOUS CATHETERS
SYRINGES AND NEEDLES
SKIN PREP ANTISEPTIC
HIGH PRESSURE SYRINGES
Biotronix Healthcare Poliglecaprone 25 sutures are synthetic absorbable sutures composed of a copolymer of glycolide and epsilon-caprolactone.
Biotronix Healthcare Poliglecaprone 25 sutures has minimal tissue reactivity during the absorption process, superior tensile strength and excellent knotting security. Biotronix Poliglecaprone 25 sutures are a reliable rapid absorbtion suture.
Poliglecaprone 25 sutures are ideal for use in soft tissue approximation and or ligation, but for use in cardiovascular, neurological procedures microsurgery and ophthalmic surgery.
Characteristics of Biotronix Healthcare Poliglecaprone 25 sutures:
• Smooth tissue passage
• Minimal tissue reactivity
• Excelent handling properties
• High pliability
• Complete absorption in 90 to 120 days from implantation
Individually packaged 12 or 36 per box.
This suture, being absorbable, should not be used where extended approximation of tissue is required. The use of this suture may be inappropriate in elderly, malnourished, and debilitated patients, or in patients suffering from conditions that may delay wound healing. Not for use in cardiovascular or neurological surgery, microsurgery, or ophthalmic surgery.
Do not resterilize; resterilization may alter the physical properties of this suture. Do not use if package is open or damaged or if the expiration date has been exceeded. Discard open, unused suture. Users should exercise caution when handling surgical needles to avoid inadvertent needle sticks. Discard used needles in a “sharps” container. Avoid storing product at elevated temperatures.
Skin sutures which must remain in place longer than 7 days may cause localized irritation and should be snipped off or removed as indicated. Subcuticular sutures should be placed as deeply as possible to minimize the erythema and induration normally associated with absorption.
Consideration should be taken in the use of absorbable sutures in tissue with poor blood supply as suture extrusion and delayed absorption may occur. In handling this or any other suture material, care should be taken to avoid damage from handling. Avoid crushing or crimping damage due to the application of surgical instruments such as forceps or needle holders.
PGCL suture knots must be properly placed to be secure. Adequate knot security requires the accepted surgical technique of flat, square ties, with additional throws as warranted by surgical circumstance and the experience of the surgeon. The use of additional throws may be particularly appropriate when tying
monofilaments. As with any foreign body, prolonged contact of this or any other suture with salt solutions, such as those found in the urinary or biliary tracts, may result in calculus formation. As an absorbable suture, PGCL suture may act transiently as a foreign body. Acceptable surgical procedure must be followed with respect to drainage and closure of contaminated or infected wounds. Users should be familiar with surgical procedures and techniques involving absorbable sutures before employing PGCL sutures for wound closure, as the risk of wound dehiscence may vary with the site of application and the suture material used.
Adverse effects associated with the use of this device include wound dehiscence, failure to provide adequate wound support in sites where expansion, stretching, or distention occur, failure to provide adequate wound support in elderly, malnourished, and debilitated patients or in patients suffering from conditions that may delay wound healing, infection, minimal acute inflammatory tissue reaction, localized irritation when skin sutures are left in place for greater than 7 days, suture extrusion and delayed absorption in tissue with poor blood supply, calculi formation when prolonged contact with salt solution occurs, enhanced bacterial infectivity, and transitory local irritation.
Rapid Polyglycolic Acid
Note: Biotronix Healthcare is a global healthcare medical device provider. The products on this website may not be registered, licensed or available in all countries. Please consult a product catalog, customer service or your sales representative for availability in your area. For product usage please refer to indications of use and product labeling. Please see the Instructions for Use for a complete listing of the indications, contraindications, warnings and precautions.
4 Robert Speck Parkway #1501
Mississauga, Ontario L4Z 1S1
Toll Free: 866-936-7314
Copyright © 2015 Biotronix Healthcare Inc.